Fresenius SE & Co. KGaA (FSNUF)
USD 34.66
(0.0%)
USD 34.66
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 5.05 Billion EUR | -52.84% |
| 2022 | 10.72 Billion EUR | 4.02% |
| 2021 | 10.31 Billion EUR | -0.05% |
| 2020 | 10.31 Billion EUR | -0.31% |
| 2019 | 10.34 Billion EUR | 5.23% |
| 2018 | 9.83 Billion EUR | -6.13% |
| 2017 | 10.47 Billion EUR | 14.77% |
| 2016 | 9.12 Billion EUR | 6.96% |
| 2015 | 8.53 Billion EUR | 24.73% |
| 2014 | 6.84 Billion EUR | 7.19% |
| 2013 | 6.38 Billion EUR | 1.51% |
| 2012 | 6.28 Billion EUR | 11.51% |
| 2011 | 5.63 Billion EUR | 5.88% |
| 2010 | 5.32 Billion EUR | 14.83% |
| 2009 | 4.63 Billion EUR | 18.08% |
| 2008 | 3.92 Billion EUR | 6.8% |
| 2007 | 3.67 Billion EUR | 7.36% |
| 2006 | 3.42 Billion EUR | 32.33% |
| 2005 | 2.58 Billion EUR | 8.96% |
| 2004 | 2.37 Billion EUR | 4.39% |
| 2003 | 2.27 Billion EUR | -6.57% |
| 2002 | 2.43 Billion EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.4 Billion EUR | 8.4% |
| 2024 Q2 | 1.22 Billion EUR | -13.02% |
| 2023 Q3 | 1.27 Billion EUR | -45.48% |
| 2023 Q1 | 2.51 Billion EUR | -9.81% |
| 2023 FY | 5.05 Billion EUR | -52.84% |
| 2023 Q2 | 2.33 Billion EUR | -7.09% |
| 2023 Q4 | 1.29 Billion EUR | 1.97% |
| 2022 Q1 | 2.55 Billion EUR | -5.68% |
| 2022 Q3 | 2.7 Billion EUR | 1.01% |
| 2022 Q4 | 2.78 Billion EUR | 2.92% |
| 2022 FY | 10.72 Billion EUR | 4.02% |
| 2022 Q2 | 2.67 Billion EUR | 4.69% |
| 2021 FY | 10.31 Billion EUR | -0.05% |
| 2021 Q1 | 2.45 Billion EUR | -5.57% |
| 2021 Q2 | 2.61 Billion EUR | 6.51% |
| 2021 Q3 | 2.52 Billion EUR | -3.63% |
| 2021 Q4 | 2.71 Billion EUR | 7.49% |
| 2020 Q4 | 2.6 Billion EUR | 3.95% |
| 2020 Q3 | 2.5 Billion EUR | -1.84% |
| 2020 Q1 | 2.68 Billion EUR | -1.32% |
| 2020 FY | 10.31 Billion EUR | -0.31% |
| 2020 Q2 | 2.55 Billion EUR | -4.92% |
| 2019 Q1 | 2.5 Billion EUR | -4.43% |
| 2019 FY | 10.34 Billion EUR | 5.23% |
| 2019 Q2 | 2.55 Billion EUR | 2.16% |
| 2019 Q3 | 2.56 Billion EUR | 0.35% |
| 2019 Q4 | 2.71 Billion EUR | 5.92% |
| 2018 FY | 9.83 Billion EUR | -6.13% |
| 2018 Q4 | 2.62 Billion EUR | 9.44% |
| 2018 Q3 | 2.39 Billion EUR | -3.55% |
| 2018 Q2 | 2.48 Billion EUR | 6.16% |
| 2018 Q1 | 2.33 Billion EUR | -11.81% |
| 2017 Q4 | 2.65 Billion EUR | 6.42% |
| 2017 FY | 10.47 Billion EUR | 14.77% |
| 2017 Q2 | 2.64 Billion EUR | -1.93% |
| 2017 Q1 | 2.69 Billion EUR | 8.72% |
| 2017 Q3 | 2.49 Billion EUR | -5.68% |
| 2016 Q1 | 2.14 Billion EUR | -6.63% |
| 2016 FY | 9.12 Billion EUR | 6.96% |
| 2016 Q4 | 2.47 Billion EUR | 7.32% |
| 2016 Q3 | 2.3 Billion EUR | 4.81% |
| 2016 Q2 | 2.2 Billion EUR | 2.85% |
| 2015 Q4 | 2.29 Billion EUR | 4.61% |
| 2015 FY | 8.53 Billion EUR | 24.73% |
| 2015 Q2 | 2.12 Billion EUR | 10.23% |
| 2015 Q1 | 1.92 Billion EUR | 1.05% |
| 2015 Q3 | 2.19 Billion EUR | 3.25% |
| 2014 Q2 | 1.64 Billion EUR | 8.43% |
| 2014 Q3 | 1.77 Billion EUR | 7.65% |
| 2014 Q4 | 1.9 Billion EUR | 7.56% |
| 2014 FY | 6.84 Billion EUR | 7.19% |
| 2014 Q1 | 1.51 Billion EUR | -9.54% |
| 2013 Q1 | 1.52 Billion EUR | -9.32% |
| 2013 Q3 | 1.58 Billion EUR | -0.44% |
| 2013 Q4 | 1.67 Billion EUR | 5.87% |
| 2013 FY | 6.38 Billion EUR | 1.51% |
| 2013 Q2 | 1.59 Billion EUR | 4.19% |
| 2012 Q2 | 1.58 Billion EUR | 10.15% |
| 2012 Q1 | 1.43 Billion EUR | -5.08% |
| 2012 FY | 6.28 Billion EUR | 11.51% |
| 2012 Q4 | 1.68 Billion EUR | 6.71% |
| 2012 Q3 | 1.57 Billion EUR | -0.38% |
| 2011 Q4 | 1.51 Billion EUR | 7.37% |
| 2011 Q1 | 1.32 Billion EUR | -3.21% |
| 2011 FY | 5.63 Billion EUR | 5.88% |
| 2011 Q2 | 1.38 Billion EUR | 4.3% |
| 2011 Q3 | 1.41 Billion EUR | 2.02% |
| 2010 Q3 | 1.42 Billion EUR | 4.41% |
| 2010 FY | 5.32 Billion EUR | 14.83% |
| 2010 Q1 | 1.17 Billion EUR | -4.01% |
| 2010 Q4 | 1.37 Billion EUR | -3.52% |
| 2010 Q2 | 1.36 Billion EUR | 16.03% |
| 2009 Q4 | 1.22 Billion EUR | 5.71% |
| 2009 Q3 | 1.15 Billion EUR | -1.03% |
| 2009 Q2 | 1.16 Billion EUR | 6.96% |
| 2009 Q1 | 1.09 Billion EUR | 0.0% |
| 2009 FY | 4.63 Billion EUR | 18.08% |
| 2008 FY | 3.92 Billion EUR | 6.8% |
| 2007 FY | 3.67 Billion EUR | 7.36% |
| 2006 FY | 3.42 Billion EUR | 32.33% |
| 2005 FY | 2.58 Billion EUR | 8.96% |
| 2004 FY | 2.37 Billion EUR | 4.39% |
| 2003 FY | 2.27 Billion EUR | -6.57% |
| 2002 FY | 2.43 Billion EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| The Amacore Group, Inc. | 9.39 Million USD | -53722.138% |
| Arem Pacific Corporation | 239.16 Thousand USD | -2114784.472% |
| Assisted 4 Living, Inc. | 712.32 Thousand USD | -709970.137% |
| BioCorRx Inc. | 53.17 Thousand USD | -9512067.601% |
| Bionik Laboratories Corp. | 989.87 Thousand USD | -510872.575% |
| Banyan Corp. | 5 Million USD | -100985.399% |
| Clearday, Inc. | -6.84 Million USD | 73943.76% |
| Dental Patient Care America, Inc. | 3.24 Million USD | -155804.057% |
| Quantum Medical Transport, Inc. | 1097.61 USD | -460819316.733% |
| Empower Clinics Inc. | 1.96 Million USD | -256909.191% |
| First Choice Healthcare Solutions, Inc. | -12.19 Thousand USD | 41472713.972% |
| Selectis Health, Inc. | 5.4 Million USD | -93443.224% |
| Ethema Health Corporation | 4.66 Million USD | -108235.331% |
| HealthLynked Corp. | 2.34 Million USD | -215247.581% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 6.78 Million USD | -74451.244% |
| JRSIS Health Care Corporation | 483.05 Thousand USD | -1046994.406% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 143.69 Million USD | -3419.887% |
| MedSmart Group Inc. | -19.03 Thousand USD | 26568016.798% |
| North America Frac Sand, Inc. | 73.25 Thousand USD | -6904453.893% |
| Nova Leap Health Corp. | 9.76 Million USD | -51679.323% |
| Nexteligent Holdings, Inc. | 351.66 Thousand USD | -1438208.835% |
| PAO Group, Inc. | - USD | -Infinity% |
| Primemd Inc. | 10.5 Million USD | -48063.704% |
| Raffles Medical Group Ltd | 239.4 Million USD | -2012.726% |
| Ryman Healthcare Limited | 260.65 Million USD | -1840.52% |
| Stem Cell Authority, Ltd. | - USD | -Infinity% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | -1.21 Million USD | 417681.347% |
| Mycotopia Therapies, Inc. | -61.21 Thousand USD | 8262510.768% |
| U.S. NeuroSurgical Holdings, Inc. | -20 Thousand USD | 25290100.0% |
| Veltex Corporation | 694.58 Thousand USD | -728103.563% |
| World Financial Holding Group | - USD | -Infinity% |
| Xcelerate Inc. | 294.11 Thousand USD | -1719623.783% |